A decision analysis model identifies the interval of efficacy for transarterial chemoembolization (TACE) in cirrhotic patients with hepatocellular carcinoma awaiting liver transplantation. [electronic resource]
- Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract Oct 2007
- 1328-32 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1091-255X
10.1007/s11605-007-0211-2 doi
Carcinoma, Hepatocellular--therapy Decision Support Techniques Disease Progression Embolization, Therapeutic Humans Liver Neoplasms--therapy Liver Transplantation Patient Dropouts Time Factors Waiting Lists